Eradication of minimal residual disease improves overall...

British Journal of Haematology 2017 / 02 Vol. 176; Iss. 4

Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation

Varghese, Abraham M., Howard, Dena R., Pocock, Christopher, Rawstron, Andy C., Follows, George, McCarthy, Helen, Dearden, Claire, Fegan, Christopher, Milligan, Donald, Smith, Alexandra F., Gregory, Wa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
176
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.14342
Date:
February, 2017
File:
PDF, 458 KB
english, 2017
Conversion to is in progress
Conversion to is failed